Tetsuo Maruyama Selected Research

Uridine Diphosphate Glucose (UDP Glucose)

11/2020	UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells.
6/2009	The UDP-glucose receptor P2RY14 triggers innate mucosal immunity in the female reproductive tract by inducing IL-8.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuo Maruyama Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 02/2007
5	Endometriosis 02/2022 - 06/2005
3	Leiomyoma (Uterine Fibroids) 01/2022 - 10/2013
3	Infertility (Sterility) 10/2014 - 01/2003
3	Carcinogenesis 10/2013 - 06/2002
3	Sarcoma (Soft Tissue Sarcoma) 01/2013 - 03/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 02/2007
2	Hypoxia (Hypoxemia) 01/2021 - 08/2015
2	Hemorrhage 07/2020 - 01/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 06/2017 - 01/2015
2	Hypothyroidism 06/2017 - 01/2013
2	Uterine Hemorrhage (Uterine Bleeding) 09/2015 - 10/2013
2	Pelvic Pain 09/2015 - 01/2013
2	Primary Ovarian Insufficiency 01/2015 - 02/2009
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2013 - 04/2006
2	Adenocarcinoma 02/2007 - 12/2005
1	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 01/2022
1	Gonadal Dysgenesis (Gonadal Agenesis) 01/2022
1	Vascular Remodeling 11/2020
1	Shock 07/2020
1	Disseminated Intravascular Coagulation 07/2020
1	Syncope (Fainting) 07/2020
1	Amniotic Fluid Embolism 07/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2017
1	Thrombophilia 06/2017
1	Spontaneous Abortion (Miscarriage) 06/2017
1	Triploidy 01/2016
1	Gynatresia 09/2015
1	Atrophy 09/2015
1	Choriocarcinoma 07/2015
1	Anemia 10/2013
1	Dysmenorrhea (Menstrual Pain) 01/2013
1	Dyspareunia 01/2013
1	Pain (Aches) 01/2013
1	Ovarian Hyperstimulation Syndrome 01/2013
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 06/2009
1	Leukocytosis (Pleocytosis) 06/2009
1	Inflammation (Inflammations) 06/2009
1	Infections 06/2009
1	Carcinoma (Carcinomatosis) 01/2008
1	Endometrial Hyperplasia 01/2008

Drug/Important Bio-Agent (IBA)

4	Estrogens (Estrogen)FDA Link 09/2015 - 02/2007
4	Progesterone FDA LinkGeneric 09/2015 - 02/2007
4	Proteins (Proteins, Gene)FDA Link 10/2007 - 06/2002
3	Phosphotransferases (Kinase)IBA 01/2022 - 03/2008
3	SteroidsIBA 08/2015 - 02/2007
3	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2015 - 05/2005
3	src-Family KinasesIBA 01/2013 - 03/2008
3	GlycodelinIBA 10/2007 - 12/2005
3	Histone Deacetylase InhibitorsIBA 02/2007 - 06/2005
2	NucleotidesIBA 01/2022 - 06/2009
2	Uridine Diphosphate Glucose (UDP Glucose)IBA 11/2020 - 06/2009
2	Hormones (Hormone)IBA 06/2017 - 02/2007
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2015 - 05/2005
2	Vorinostat FDA Link 10/2007 - 02/2007
2	Tyrosine (L-Tyrosine)FDA Link 01/2004 - 06/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2004 - 06/2002
2	ElementsIBA 01/2004 - 06/2002
1	Cadherins (E-Cadherin)IBA 02/2022
1	Lewis X AntigenIBA 02/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Annexin A5IBA 01/2022
1	Mediator ComplexIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	SmokeIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 07/2020
1	Indicators and Reagents (Reagents)IBA 09/2017
1	Antinuclear AntibodiesIBA 06/2017
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 06/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Steroid Receptors (Steroid Receptor)IBA 09/2015
1	Estriol (Epiestriol)IBA 07/2015
1	AutoantibodiesIBA 01/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2013
1	Transcription Factor 7-Like 2 ProteinIBA 10/2013
1	CateninsIBA 10/2013
1	Nerve Growth Factor (NGF)IBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	FSH Receptors (FSH Receptor)IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2009
1	UridineIBA 06/2009
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2009
1	CytokinesIBA 06/2009
1	Adenosine Triphosphate (ATP)IBA 06/2009
1	Small Interfering RNA (siRNA)IBA 06/2009
1	Interleukin-8 (Interleukin 8)IBA 06/2009
1	Androgen Receptors (Androgen Receptor)IBA 02/2009
1	STAT5 Transcription FactorIBA 10/2008
1	enhanced green fluorescent proteinIBA 01/2008
1	Pharmaceutical PreparationsIBA 10/2007
1	Capsules (Microcapsules)IBA 02/2007

Therapy/Procedure

4	Therapeutics 01/2019 - 02/2007
2	Hysterectomy 01/2022 - 09/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2015
1	Drug Therapy (Chemotherapy) 01/2015